Literature DB >> 24519376

Carcinoma ex-Schneiderian papilloma (malignant transformation): a clinicopathologic and immunophenotypic study of 20 cases combined with a comprehensive review of the literature.

Jeremy Nudell1, Simion Chiosea, Lester D R Thompson.   

Abstract

Schneiderian papilloma (SP) are uncommon tumors with malignant transformation even less common. The histologic criteria to define malignant transformation are not well developed nor is the immunohistochemical profile reported in a large series of carcinomas. 20 cases of malignant transformation of SP included 7 females and 13 males, aged 38-86 years (mean 60.7 years). Patients presented most frequently with a mass (n = 11) and obstructive symptoms (n = 7), present for 38.7 months (mean). Most patients had no previous history of SP (n = 13); metachronous carcinoma was identified in 7 patients an average of 34.4 months after the first diagnosis of SP, with 1-4 recurrences of SP. With a mean size of 4.1 cm, the majority of tumors involved a combination of more than one anatomic site (n = 10), followed by the maxillary sinus only (n = 5) or nasal cavity only (n = 3). Histologically, 17 were inverted and 3 exophytic type SP. There were 17 squamous cell carcinomas, 2 mucoepidermoid carcinomas and 1 sinonasal undifferentiated carcinoma, comprising from 10 to 95 % of the tumor volume. Malignant histologic features included atypical mitoses, necrosis, bone invasion, lymphovascular invasion, decreased transmigrating neutrophils, paradoxical maturation, dyskeratosis and/or perineural invasion (n = 3). Patients tended to present with advanced stage (n = 14, Stage III and IV). Immunohistochemical studies showed positive reactions in the malignancies for CK5/6 (86 %), p63 (86 %), CK7 (luminal, 50 %), p53 (83 %), and p16 (25 %). In situ hybridization detected human papillomavirus in 26 %. Surgery was often accompanied by radiation therapy (n = 13), with a mean of 2.4 years of follow-up. Five patients developed a recurrence between 0.8 and 3.3 years. Carcinomas ex-SP are less common and are associated with better outcome than previously reported. Patients tend to present with a synchronous carcinoma, developing in an inverted type SP, with squamous cell carcinoma the most common malignancy. Development of metachronous carcinomas ex-SP was always preceded by SP recurrence in this series.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24519376      PMCID: PMC4126921          DOI: 10.1007/s12105-014-0527-7

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  46 in total

1.  Malignant transformation of exophytic Schneiderian papilloma of the nasal cavity.

Authors:  Tadashi Terada
Journal:  Pathol Int       Date:  2012-02-14       Impact factor: 2.534

2.  Markers of malignant transformation of sinonasal inverted papilloma.

Authors:  H Katori; A Nozawa; M Tsukuda
Journal:  Eur J Surg Oncol       Date:  2005-10       Impact factor: 4.424

3.  Malignant tumors of the nose and paranasal sinuses: hospital of the University of Pennsylvania experience 1990-1997.

Authors:  R P Tufano; N A Mokadam; K T Montone; G S Weinstein; A A Chalian; P F Wolf; R S Weber
Journal:  Am J Rhinol       Date:  1999 Mar-Apr

Review 4.  Treatment outcomes in the management of inverted papilloma: an analysis of 160 cases.

Authors:  William Lawson; Matthew R Kaufman; Hugh F Biller
Journal:  Laryngoscope       Date:  2003-09       Impact factor: 3.325

5.  Sinonasal papillomas: clinicopathologic review of 40 patients with inverted and oncocytic schneiderian papillomas.

Authors:  Matthew R Kaufman; Margaret S Brandwein; William Lawson
Journal:  Laryngoscope       Date:  2002-08       Impact factor: 3.325

6.  Histological features and malignant transformation of inverted papilloma.

Authors:  Georg Eggers; Henrike Eggers; Nicola Sander; Friedrich Kössling; Reinhard Chilla
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-07-17       Impact factor: 2.503

7.  Different options for treatment of inverting papilloma of the nose and paranasal sinuses: a report of 41 cases.

Authors:  S R Dolgin; V D Zaveri; R R Casiano; A J Maniglia
Journal:  Laryngoscope       Date:  1992-03       Impact factor: 3.325

8.  Cell proliferation, apoptosis, and apoptosis inhibition in malignant transformation of sinonasal inverted papilloma.

Authors:  Hideaki Katori; Akinori Nozawa; Mamoru Tsukuda
Journal:  Acta Otolaryngol       Date:  2007-05       Impact factor: 1.494

9.  Inverted papilloma of the nose and paranasal sinuses: a study of 67 patients.

Authors:  K E Outzen; A Grøntved; K Jørgensen; P P Clausen
Journal:  Clin Otolaryngol Allied Sci       Date:  1991-06

10.  Inverted papilloma.

Authors:  M C Weissler; W W Montgomery; P A Turner; S K Montgomery; M P Joseph
Journal:  Ann Otol Rhinol Laryngol       Date:  1986 May-Jun       Impact factor: 1.547

View more
  29 in total

1.  Transcriptionally Active High-Risk Human Papillomavirus is Not a Common Etiologic Agent in the Malignant Transformation of Inverted Schneiderian Papillomas.

Authors:  Lisa M Rooper; Justin A Bishop; William H Westra
Journal:  Head Neck Pathol       Date:  2017-02-08

Review 2.  New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base.

Authors:  Lester D R Thompson; Alessandro Franchi
Journal:  Virchows Arch       Date:  2017-04-25       Impact factor: 4.064

Review 3.  OSPs and ESPs and ISPs, Oh My! An Update on Sinonasal (Schneiderian) Papillomas.

Authors:  Justin A Bishop
Journal:  Head Neck Pathol       Date:  2017-03-20

4.  A Subset of Sinonasal Non-Intestinal Type Adenocarcinomas are Truly Seromucinous Adenocarcinomas: A Morphologic and Immunophenotypic Assessment and Description of a Novel Pitfall.

Authors:  Bibianna Purgina; Jassem M Bastaki; Umamaheswar Duvvuri; Raja R Seethala
Journal:  Head Neck Pathol       Date:  2015-02-19

Review 5.  Malignant transformation of sinonasal inverted papilloma and related genetic alterations: a systematic review.

Authors:  M Re; F M Gioacchini; A Bajraktari; M Tomasetti; S Kaleci; C Rubini; A Bertini; G Magliulo; E Pasquini
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-21       Impact factor: 2.503

Review 6.  Imaging features of benign mass lesions in the nasal cavity and paranasal sinuses according to the 2017 WHO classification.

Authors:  Hiroyuki Tatekawa; Taro Shimono; Masahiko Ohsawa; Satoshi Doishita; Shinichi Sakamoto; Yukio Miki
Journal:  Jpn J Radiol       Date:  2018-04-25       Impact factor: 2.374

Review 7.  Sinonasal Squamous Cell Carcinoma: A Review with Emphasis on Emerging Histologic Subtypes and the Role of Human Papillomavirus.

Authors:  James S Lewis
Journal:  Head Neck Pathol       Date:  2016-02-01

8.  Sinonasal Squamous Cell Carcinoma: Etiology, Pathogenesis, and the Role of Human Papilloma Virus.

Authors:  Katya Elgart; Daniel L Faden
Journal:  Curr Otorhinolaryngol Rep       Date:  2020-06

Review 9.  Rare Diseases of the Nose, the Paranasal Sinuses, and the Anterior Skull Base.

Authors:  Fabian Sommer
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

Review 10.  Middle Ear and Temporal Bone Papilloma: A Clinicopathologic Study and Comprehensive Literature Review of 57 Cases.

Authors:  Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.